Solo Smart Heart Valve

FDA Premarket Approval P130011 S009

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

To extend the maximum shipping time between abattoirs and the manufacturing site for bovine tissue from 48 hours to 96 hours

DeviceSolo Smart Heart Valve
Generic NameHeart-valve, Non-allograft Tissue
ApplicantLivaNova Canada Corp.
Date Received2020-03-02
Decision Date2020-04-03
PMAP130011
SupplementS009
Product CodeLWR 
Advisory CommitteeCardiovascular
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address LivaNova Canada Corp. 5005 North Fraser Way burnaby V5J 5

Supplemental Filings

Supplement NumberDateSupplement Type
P130011Original Filing
S011 2022-06-29 30-day Notice
S010 2022-03-03 30-day Notice
S009 2020-03-02 30-day Notice
S008 2020-01-13 30-day Notice
S007 2019-03-01 30-day Notice
S006 2018-02-07 30-day Notice
S005 2016-08-11 135 Review Track For 30-day Notice
S004 2016-03-31 30-day Notice
S003 2016-01-27 135 Review Track For 30-day Notice
S002 2015-12-07 135 Review Track For 30-day Notice
S001 2015-06-22 30-day Notice

NIH GUDID Devices

Device IDPMASupp
00896208000498 P130011 000
00896208000481 P130011 000
00896208000474 P130011 000
00896208000467 P130011 000
00896208000405 P130011 000
00896208000399 P130011 000
00896208000382 P130011 000
00896208000375 P130011 000

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.